Alzheimer'
Conditions
Interventions
None listed
Sponsors
Osaka University
Shionogi pharmaceutical company
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Alzheimer's disease patients and non-AD patients
Exclusion criteria
Exclusion criteria: other dementia than AD
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| We aim to analyze Abeta production mechanism and effects of disease course modifiers. | — |
Countries
Japan
Contacts
Public ContactMasayasu Okochi
Osaka University Graduate School of Medicine Department of Neuropsychiatry
Outcome results
None listed